Researchers report that a new blood test may detect advanced stages of chronic traumatic encephalopathy (CTE) in living people, based on two recently published studies. Current diagnosis of CTE relies on examination of brain tissue after death, so the findings are presented as a step toward earlier detection.
Scientific American frames the work as a potentially important breakthrough that could be validated through larger trials, with the goal of enabling doctors to diagnose CTE before death. ESPN similarly focuses on the blood test’s potential usefulness, describing it as a method that could identify advanced stages during life.
The New York Post highlights the test as a “game changer,” emphasizing the contrast with current limits of diagnosis and repeating the core claim that living detection is newly possible. Across outlets, the main shared context is the shift from post-mortem confirmation to a prospective, blood-based approach that still needs broader validation.